Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avecho Biotechnology Ord Shs V.AVE


Primary Symbol: AVEFF

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.


OTCPK:AVEFF - Post by User

Post by TallerCraigon Nov 04, 2017 3:16am
314 Views
Post# 26905220

How ESI Energy Services Told you AVE Q3 will be HUGE!!!

How ESI Energy Services Told you AVE Q3 will be HUGE!!!After watching all these energy service names report revenue growth in the 50-100% Revenue growth and 100%+ EBITDA growth and still don’t think it will match to what Aveda will be putting up in a week or two.  Its all thanks to Asset Utilization Gains and the direct correlation this has on gross margins.
 
I am going to use ESI Energy Services (OPI.c) who has already reported Q3 as a case fact why I am so bullish on this next Q for Aveda. So ESI Energy is in a similar business to Aveda as ESI is a supplier of padding equipment and pipe layers for the Energy market.  Like Aveda, ESI business south of the boarder has been booming with it now making up essentially all its revenue base.
 
If you look at their Asset Utilization ex Amort/Dep level YTD is where it gets real bullish. ESI Energy Services Asset Utilization (Q1: 35%, Q2: 45% and Q3: 60%) associated with gross margin ex Amort/Dep expansion of (Q1: 52%, Q2: 67%, Q3: 75%). Now compare that to Aveda Asset Utilization (Q1: 30%, Q2: 40% and Q3: ???) and Gross Margins ex Amort/Dep (Q1: 17%, Q2: 20%, Q3: ???). You must be able to see how Aveda is going to put up Asset Utilization Growth and Gross Margin expansion!!!
 
See Prior Post for numbers for associated numbers to my larger thesis on Aveda.

<< Previous
Bullboard Posts
Next >>